ROLE OF VITAMIN D3 IN THE MANAGEMENT OF SICKLE CELL DISEASE (SCD)
Not Applicable
- Conditions
- Haematological Disorders
- Registration Number
- PACTR202202814392581
- Lead Sponsor
- Brain and Body Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Age: Patients between 1 year and 12 years
Gives informed consent to participate
Sickle cell disease, confirmed by laboratory tests
Exclusion Criteria
Age: < 1 year and > 12years
Consume more than 1000 IU per day of vitamin D from all supplemental sources combined (individual vitamin D supplements, calcium plus vitamin D supplements, medications with vitamin D, and multivitamins) in the past 4 weeks.
Unable to complete questionnaires or adhere to study requirements
Presence of complications like leg ulcers, strokes, and avascular necrosis of the head of the femur
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method